158 related articles for article (PubMed ID: 7667389)
1. Cardioselective derivatives of 2,2-diphenyl-2-ethylthioacetate do not discriminate between m2 and m3 muscarinic receptors expressed in CHO cells.
Hu J; Wang SZ; Scapecchi S; Gualtieri F; el-Fakahany EE
Pharmacology; 1995 May; 50(5):273-85. PubMed ID: 7667389
[TBL] [Abstract][Full Text] [Related]
2. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
3. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-trisphosphate and adenosine 3',5'-cyclic monophosphate accumulation in Chinese hamster ovary cells.
Burford NT; Tobin AB; Nahorski SR
J Pharmacol Exp Ther; 1995 Jul; 274(1):134-42. PubMed ID: 7616390
[TBL] [Abstract][Full Text] [Related]
4. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
Hu J; Wang SZ; Forray C; el-Fakahany EE
Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
FEBS Lett; 1995 Dec; 377(2):275-9. PubMed ID: 8543067
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
Watson N; Daniels DV; Ford AP; Eglen RM; Hegde SS
Br J Pharmacol; 1999 May; 127(2):590-6. PubMed ID: 10385263
[TBL] [Abstract][Full Text] [Related]
7. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
8. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
[TBL] [Abstract][Full Text] [Related]
9. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
10. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors.
Hou VY; Hirshman CA; Emala CW
Anesthesiology; 1998 Mar; 88(3):744-50. PubMed ID: 9523819
[TBL] [Abstract][Full Text] [Related]
12. Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.
Lysíková M; Fuksová K; Elbert T; Jakubík J; Tucek S
Br J Pharmacol; 1999 Jul; 127(5):1240-6. PubMed ID: 10455271
[TBL] [Abstract][Full Text] [Related]
13. Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors.
Michal P; Lysíková M; El-Fakahany EE; Tucek S
Eur J Pharmacol; 1999 Jul; 376(1-2):119-25. PubMed ID: 10440097
[TBL] [Abstract][Full Text] [Related]
14. Selective antagonism activity of alkaloids from bulbs Fritillariae at muscarinic receptors: functional studies.
Lin BQ; Ji H; Li P; Jiang Y; Fang W
Eur J Pharmacol; 2006 Dec; 551(1-3):125-30. PubMed ID: 17027747
[TBL] [Abstract][Full Text] [Related]
15. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination.
Griffin MT; Hsu JC; Shehnaz D; Ehlert FJ
Biochem Pharmacol; 2003 Apr; 65(8):1227-41. PubMed ID: 12694864
[TBL] [Abstract][Full Text] [Related]
17. Coupling of muscarinic m1, m2 and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins.
Burford NT; Tobin AB; Nahorski SR
Eur J Pharmacol; 1995 Apr; 289(2):343-51. PubMed ID: 7621908
[TBL] [Abstract][Full Text] [Related]
18. Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells.
Hirota K; Hashimoto Y; Lambert DG
Anesth Analg; 2002 Dec; 95(6):1607-10, table of contents. PubMed ID: 12456425
[TBL] [Abstract][Full Text] [Related]
19. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
20. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
